Method for early diagnosing acute kidney injury caused by contrast medium by utilizing MBL (mannan-binding lectin)
A technology for acute kidney injury and early diagnosis, applied in the medical field, can solve problems such as poor specificity and delay in diagnosis time
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment Construction
[0006] Nowadays, there are more and more opinions that SCr is not a sensitive, specific and reliable diagnostic index for AKI. The study of new diagnostic markers can provide the basis for early diagnosis, early intervention and guiding treatment. Compared with serum and other body fluid samples, urine has a relatively simple protein composition, good stability, and easy analysis. It can be used for the detection of various human diseases, especially urinary system diseases. It is a better clinical specimen than serum.
[0007] At present, the applicant has found that urinary interleukin-18 (IL-18) and urinary neutrophil gelatinase-associated apolipoprotein (NGAL) may be used as early diagnostic markers of AKI, but the urine mannose-binding lectin For acute kidney disease, especially the diagnostic value of contrast agent-induced acute kidney injury, there is no related report.
[0008] Therefore, the applicant proposes a method for early diagnosis of acute kidney injury caus...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com